Combination therapy IO + Chemo in Triple Negative Breast Cancer - Schmid

Article and Video CATEGORIES

Cancer Journey

ABOUT

GRACE Videos and Articles

Combination therapy IO + Chemo in Triple Negative Breast Cancer - Schmid

dbrock

Thu, 05/16/2019 - 16:09

Author

GRACE Videos and Articles

GRACE and PRIME Oncology have partnered to present to you information from the prIME Oncology satellite symposium held in conjunction with the 2018 San Antonio Breast Cancer Symposium (SABCS).

In the following series of videos, faculty discuss therapeutic options for triple-negative breast cancer. Topics discussed include the biology of triple-negative breast cancer, current treatment options, novel targeted treatments, PARP inhibitors, and immunotherapy.

To start a conversation on this topic, visit https://cancergrace.org/forums/breast-cancer.

Video Language

English

Please feel free to offer comments and raise questions in our
discussion forums.

Join The conversation

Next Previous link

Previous Post Next Post

Article

The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.